TY  - JOUR
T1  - DO β-blockers slow down melanoma progression?
AU  - Lens M
Y1  - 2011/10/10
N1  - 10.1001/archinternmed.2011.483
JO  - Archives of Internal Medicine
SP  - 1686
EP  - 1687
VL  - 171
IS  - 18
N2  - 
Although De Giorgi et al1 were the first to report association between β-blockers and tumor progression in patients with melanoma, limited evidence suggests that β-blocker therapy may reduce tumor recurrence in other malignant diseases.2

SN  - 0003-9926
M3  - doi: 10.1001/archinternmed.2011.483
UR  - http://dx.doi.org/10.1001/archinternmed.2011.483
ER  -